CORT — CORCEPT THERAPEUTICS INC

Ownership history in Checkpoint Capital L.P.  ·  7 quarters on record

This page tracks every 13F SEC filing in which Checkpoint Capital L.P. reported a position in CORCEPT THERAPEUTICS INC (CORT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
11.76% (2025 Q2)
Avg. % of fund
5.45%
First filed
2024 Q1
Last filed
2025 Q4
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 128,300 -273,095 -68.0% 1.39% $4.5M $34.80
2025 Q4 ADDED 401,395 +9,064 +2.3% 4.36% $14.0M $34.80
2025 Q3 ADDED 392,331 +48,414 +14.1% 10.92% $32.6M $83.11
2025 Q2 ADDED 343,917 +338,917 +6778.3% 11.76% $25.2M $73.40
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CORT price (monthly, adj. close)

Other funds also holding CORT

As of 2025 Q4 — sorted by position size

INGALLS & SNYDER LLC 3Y 7Y 9.19% TANAKA CAPITAL MANAGEMENT INC 3Y 7Y 7.05% Parallel Advisors, LLC 3Y 7Y 2.47% Birchview Capital, LP 3Y 7Y 1.37% S&T BANK/PA 3Y 7Y 1.03% Intrinsic Edge Capital Management LLC 3Y 7Y 0.86% Newtyn Management, LLC 3Y 7Y 0.73% FAS Wealth Partners, Inc. 3Y 7Y 0.7% Ikarian Capital, LLC 3Y 0.64% Ikarian Capital, LLC 3Y 0.5%
← Back to Checkpoint Capital L.P. Holdings